UMMC-GRENADA — History
CCN 250168 | 3-year financial timeline | COVID resilience: 83/100
🛡️ Public data only — no PHI permitted on this instance.
$64M
Latest Revenue (FY2022)
+19.8%
Revenue CAGR (3yr)
7.1%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $44M | $42M | $64M | +51.1% | +19.8% |
| Operating Expenses | $51M | $52M | $59M | +13.4% | +7.5% |
| Operating Margin | -15.4% | -23.8% | 7.1% | +129.9% | +0.0% |
| Net Income | $-7M | $-10M | $5M | +145.2% | +0.0% |
| Licensed Beds | 49 | 49 | 49 | +0.0% | +0.0% |
| Total Patient Days | 9,096 | 8,629 | 8,222 | -4.7% | -4.9% |
| Medicare Day % | 46% | 41% | 35% | -14.4% | -12.5% |
| Medicaid Day % | 14% | 17% | 16% | -4.4% | +9.2% |
COVID Impact & Recovery
Resilience Score: 83/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +43.5% ($44M → $64M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+19.8%
This Hospital
+7.6%
State Avg
Latest Margin
7.1%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $73M | 18.4% |
| FY2024 (proj) | $83M | 29.6% |
| FY2025 (proj) | $93M | 40.9% |